1. Home
  2. FELE vs CRSP Comparison

FELE vs CRSP Comparison

Compare FELE & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Electric Co. Inc.

FELE

Franklin Electric Co. Inc.

HOLD

Current Price

$102.71

Market Cap

4.4B

ML Signal

HOLD

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$47.82

Market Cap

5.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FELE
CRSP
Founded
1944
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
5.0B
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
FELE
CRSP
Price
$102.71
$47.82
Analyst Decision
Hold
Buy
Analyst Count
2
17
Target Price
$103.50
$70.29
AVG Volume (30 Days)
282.4K
1.7M
Earning Date
04-28-2026
05-11-2026
Dividend Yield
1.10%
N/A
EPS Growth
N/A
N/A
EPS
0.77
N/A
Revenue
$2,131,250,000.00
$289,590,000.00
Revenue This Year
$6.84
$807.72
Revenue Next Year
$3.43
$172.52
P/E Ratio
$134.61
N/A
Revenue Growth
5.44
9169.85
52 Week Low
$89.54
$44.12
52 Week High
$115.82
$78.48

Technical Indicators

Market Signals
Indicator
FELE
CRSP
Relative Strength Index (RSI) 47.72 41.22
Support Level $101.97 $44.82
Resistance Level $109.70 $59.83
Average True Range (ATR) 2.90 1.67
MACD -0.23 -0.15
Stochastic Oscillator 10.33 34.28

Price Performance

Historical Comparison
FELE
CRSP

About FELE Franklin Electric Co. Inc.

Franklin Electric Co Inc designs, manufactures, and distributes water and fuel pumping systems, composed of submersible motors, pumps, electronic controls, water treatment systems, and related parts and equipment. It has three segments; The Water Systems segment designs, manufactures and sells motors, pumps, drives, electronic controls, monitoring devices, and related parts and equipment for use in groundwater, water transfer, and wastewater, The Energy Systems segment designs, manufactures and sells pumps, pipe, sumps, fittings, vapor recovery components, electronic controls, monitoring devices, and related parts and equipment for use in fueling system applications and the Distribution segment sells and provides presale support and specifications to the installing contractors.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: